Log In
Print
BCIQ
Print
Print this Print this
 

ALB 109564(a)

  Manage Alerts
Collapse Summary General Information
Company Albany Molecular Research Inc.
DescriptionSemi-synthetic analog of marketed tubulin inhibitors
Molecular Target Tubulin
Mechanism of ActionTubulin inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today